Officer Harlan Robins Files Intent to Sell $6.8M in Shares Following Recent Vesting

summarizeSummary

An officer of Adaptive Biotechnologies Corp, Harlan S. Robins, has filed a Form 144 indicating an intent to sell 470,266 shares of common stock, valued at approximately $6.83 million.

check_boxKey Events

• Officer Files Intent to Sell

  Harlan S. Robins, an officer of Adaptive Biotechnologies Corp, has filed a Form 144 to sell 470,266 shares of common stock.

• Substantial Value

  The proposed sale has an approximate market value of $6,828,262.32, representing a significant transaction.

• Shares from Vesting Awards

  The securities to be sold were acquired upon the vesting of restricted stock units and performance stock units on March 4, 2026.

• Follows Recent Sales

  This intent to sell follows previous sales by Mr. Robins in early March 2026, totaling 77,021 shares for gross proceeds of $1,355,892.14 over the past three months.

auto_awesomeAnalysis

This Form 144 indicates a significant intent to sell shares by Harlan S. Robins, an officer of Adaptive Biotechnologies Corp. The proposed sale of approximately $6.83 million in common stock represents a notable transaction for a company of this size. While the shares were acquired through the vesting of restricted and performance stock units, the substantial value and the filer's executive role make this a material event. This filing also follows a pattern of recent sales by Mr. Robins, suggesting ongoing liquidity or portfolio rebalancing. Investors should monitor the actual execution of these sales and consider the potential impact of this insider activity on market sentiment.